Total enrollment up 9.8% YoY

Revenue up 12.9% YoY

Diluted earnings per share $1.59; Adjusted EPS $1.92, growth of 28.0% YoY

Third quarter highlights

Total student enrollment 94,223, up 9.8% year-over-year Revenue $466.1 million, up 12.9% year-over-year Chamberlain University achieved ninth straight quarter of total enrollment growth, up 6.8% year-over-year, highest total enrollment in university history Walden University achieved seventh straight quarter of total enrollment growth, up 13.5% year-over-year Medical & Veterinary segment achieved total enrollment growth, up 1.2% year-over-year Robust momentum, GAAP net income $60.8 million; adjusted EBITDA $127.8 million, up 19.3% year-over-year Growth with Purpose strategy generating significant returns

Capital allocation

Completed $300 million January 2024 Board-authorized share repurchase program on May 5, 2025, representing a substantial return for shareholders New $150 million Board-authorized share repurchase program through May 2028 Net leverage 0.8x as of Mar. 31, 2025

Fiscal year 2025 guidance

Revenue $1,760 million to $1,775 million Adjusted earnings per share $6.40 to $6.60

CHICAGO, May 08, 2025--(BUSINESS WIRE)--Adtalem Global Education Inc. (NYSE: ATGE), the leading healthcare educator in the United States, today reported third quarter fiscal year 2025 results (ended Mar. 31, 2025). The Company continues to transform higher education by training the next generation of professionals at an industry-leading scale.

"Our focus on delivering flexible, personalized, tech enabled and career relevant programs for today’s modern student has driven seven consecutive quarters of enrollment growth," said Steve Beard, chairman and chief executive officer, Adtalem Global Education. "Rooted in operational excellence, our Growth with Purpose strategy continues to fuel sustainable returns. As a trusted pathway for aspiring healthcare professionals, we’re investing in innovative programs to meet rising demand, ensuring a skilled workforce that meets the needs of communities across the U.S."

Financial Highlights

Selected financial data for the three months ended Mar. 31, 2025:

Revenue of $466.1 million increased 12.9% compared with the prior year Operating income of $90.5 million, compared with $61.7 million in the prior year; adjusted operating income of $105.4 million, compared with $89.8 million in the prior year Net income of $60.8 million, compared with $36.8 million in the prior year; adjusted net income of $73.3 million, compared with $59.4 million in the prior year Diluted earnings per share of $1.59, compared with $0.93 in the prior year; adjusted earnings per share of $1.92, compared with $1.50 in the prior year Adjusted EBITDA of $127.8 million, compared with $107.1 million in the prior year; adjusted EBITDA margin of 27.4%, compared with 25.9% in the prior year

Story Continues

Business Highlights

American University of the Caribbean School of Medicine (AUC) and Ross University School of Medicine (RUSM) achieved a combined 95% first-time residency attainment rate for 2024-2025 graduates1, at least 95% attainment for the fourth consecutive year, placing more than 615 students and graduates into over 325 unique healthcare facilities with more than 130 students and graduates matching into partner clinical hospitals. The U.S. is projected to face a shortage of 187,000 physicians in 20372, exacerbating healthcare gaps, particularly in existing shortage areas. This year, more than 40% of AUC and RUSM residency placements will train in federally designated Medically Underserved Areas / Populations3, expanding access to care in underserved urban and rural communities nationwide. More than 450 students and graduates matched into primary care residencies, with over 55% training in primary care Health Professional Shortage Areas3. Ross University School of Veterinary Medicine (RUSVM) ranked first among all universities in total graduates matched into highly competitive internships and residencies in 2025 through the Veterinary Internship and Residency Matching Program. For the last five years, RUSVM has been among the top schools for matching graduates into postgraduate opportunities, providing invaluable clinical experience in specialized fields such as surgery, cardiology, internal medicine and emergency care. Walden University celebrated approximately 6,000 graduates at its 72nd commencement. Nursing, social, behavioral and other health degrees accounted for approximately 80% of the degrees awarded, further showcasing Adtalem's commitment to delivering qualified professionals at scale to the U.S. healthcare system. Chamberlain University launched "You’ve Got This, We’ve Got You," a new brand campaign that focuses on the culture of caring and support at the No. 1 largest nursing school in the U.S.

Segment Highlights

Chamberlain

$ in millions  Three Months Ended

March 31, 2025 2024 % Change Revenue  $192.6 $170.3 13.1% Operating Income  $47.5 $43.3 9.6% Adj. Operating Income  $47.5 $43.3 9.6% Adj. EBITDA  $56.8 $50.5 12.6% Total Students4  40,564 37,985 6.8%

Total student enrollment increased 6.8% compared with the prior year, driven by growth in pre-licensure and post-licensure nursing programs.

Walden

$ in millions  Three Months Ended

March 31, 2025 2024 % Change Revenue  $178.4 $150.6 18.5% Operating Income  $45.2 $23.6 91.6% Adj. Operating Income  $48.0 $31.9 50.6% Adj. EBITDA  $54.0 $35.9 50.6% Total Students4  48,526 42,751 13.5%

Total student enrollment increased 13.5% compared with the prior year, driven by growth in healthcare and non-healthcare programs.

Medical and Veterinary

$ in millions  Three Months Ended

March 31, 2025 2024 % Change Revenue  $95.0 $91.7 3.6% Operating Income  $17.8 $22.8 (21.8)% Adj. Operating Income  $17.9 $23.0 (21.9)% Adj. EBITDA  $22.9 $27.0 (15.3)% Total Students4  5,133 5,073 1.2%

Total student enrollment increased 1.2% compared to the prior year, driven by growth in veterinary.

Fiscal Year 2025 Outlook

Adtalem raises guidance for fiscal year 2025, with revenue in the range of $1,760 million to $1,775 million, approximately 11% to 12% growth year-over-year. Adjusted earnings per share to be in the range of $6.40 to $6.60, approximately 28% to 32% growth year-over-year.

Conference Call and Webcast Information

Adtalem will hold a conference call to discuss its third quarter fiscal year 2025 results today at 4:00 p.m. CT (5:00 p.m. ET).

The call can be accessed by dialing +1 877-407-6184 (U.S. participants) or +1 201-389-0877 (international participants) and stating "Adtalem earnings call" or by using conference ID:13752889. The call will be simulcast through the Adtalem investor relations website at: https://investors.adtalem.com.

Adtalem will archive a replay of the call for 30 days. To access the replay, dial +1 877-660-6853 (U.S.) or +1 201-612-7415 (international), conference ID: 13752889, or visit the Adtalem investor relations website.

About Adtalem Global Education

Adtalem Global Education is the leading provider of healthcare education in the U.S., shaping the future of healthcare by preparing a practice-ready workforce with high-quality academic programs. We innovate education pathways, align with industry needs and empower individuals to reach their full potential. Our commitment to excellence and access is reflected in our expansive network of institutions, serving over 90,000 students and supported by a strong community of approximately 350,000 alumni and nearly 10,000 dedicated employees. Visit Adtalem.com for more information and follow us on LinkedIn, Instagram and Facebook.

Cautionary Disclosure Regarding Forward-Looking Statements

Certain statements contained in this release are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact, which includes statements regarding Adtalem’s future growth. Forward-looking statements generally can be identified by the use of forward-looking terminology such as "future," "believe," "expect," "anticipate," "estimate," "plan," "intend," "may," "will," "would," "could," "can," "continue," "preliminary," "range," and similar terms. These forward-looking statements are subject to risk and uncertainties that could cause actual results to differ materially from those described in the statements. These risks and uncertainties include the risk factors described in Item 1A. "Risk Factors" of our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (SEC) and our other filings with the SEC. These forward-looking statements are based on information available to us as of the date any such statements are made, and Adtalem assumes no obligation to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results expressed or implied therein will not be realized, except as required by law.

A reconciliation of non-GAAP guidance measures to corresponding GAAP measures is not available on a forward-looking basis without unreasonable effort due to the uncertainty of special items that may be incurred in the future, although these special items could be material to Adtalem's results in accordance with GAAP.

1 First-time residency attainment rate is the percent of students attaining a 2025-26 residency position out of all graduates or expected graduates in 2024-25 who were active applicants in the 2025 NRMP match or who attained a residency position outside the NRMP match. 2 Health Resources & Services Administration (HRSA): https://bhw.hrsa.gov/data-research/projecting-health-workforce-supply-demand 3 Medically Underserved Areas and Health Professional Shortage Areas as defined by the U.S. Health Resources & Services Administration: What Is Shortage Designation? | Bureau of Health Workforce 4 Represents total students attending sessions during each institution’s most recent enrollment period in Q3 FY 2025 and Q3 FY 2024.

Adtalem Global Education Inc. Consolidated Balance Sheets (unaudited) (in thousands)  March 31,  June 30, 2025  2024 Assets:  Current assets:  Cash and cash equivalents  $ 219,017  $ 219,306 Restricted cash   2,164   1,896 Accounts and financing receivables, net   162,972   126,833 Prepaid expenses and other current assets   66,190   70,050 Total current assets   450,343   418,085 Noncurrent assets:  Property and equipment, net   250,764   248,524 Operating lease assets   198,465   176,755 Deferred income taxes   33,157   49,088 Intangible assets, net   768,279   776,694 Goodwill   961,262   961,262 Other assets, net   119,664   103,184 Assets held for sale   7,825   7,825 Total noncurrent assets   2,339,416   2,323,332 Total assets  $ 2,789,759  $ 2,741,417 Liabilities and shareholders' equity:  Current liabilities:  Accounts payable  $ 98,709  $ 102,626 Accrued payroll and benefits   72,676   71,373 Accrued liabilities   86,491   96,957 Deferred revenue   247,811   185,272 Current operating lease liabilities   34,882   31,429 Total current liabilities   540,569   487,657 Noncurrent liabilities:  Long-term debt   552,186   648,712 Long-term operating lease liabilities   193,460   167,712 Deferred income taxes   33,589   29,526 Other liabilities   37,242   38,675 Total noncurrent liabilities   816,477   884,625 Total liabilities   1,357,046   1,372,282 Commitments and contingencies  Total shareholders' equity   1,432,713   1,369,135 Total liabilities and shareholders' equity  $ 2,789,759  $ 2,741,417

Adtalem Global Education Inc. Consolidated Statements of Income (unaudited) (in thousands, except per share data)  Three Months Ended  Nine Months Ended March 31,  March 31, 2025  2024  2025  2024 Revenue  $ 466,055  $ 412,658  $ 1,331,184  $ 1,174,745 Operating cost and expense:  Cost of educational services   199,869   175,321   572,500   516,008 Student services and administrative expense   175,167   156,689   491,141   478,368 Restructuring expense   510   473   2,926   1,217 Business integration expense   —   18,450   —   30,621 Total operating cost and expense   375,546   350,933   1,066,567   1,026,214 Operating income   90,509   61,725   264,617   148,531 Interest expense   (13,074)   (16,560)   (41,465)   (48,910) Other income, net   1,898   2,871   6,779   8,648 Income from continuing operations before income taxes   79,333   48,036   229,931   108,269 Provision for income taxes   (18,539)   (10,595)   (51,716)   (21,156) Income from continuing operations   60,794   37,441   178,215   87,113 Discontinued operations:  Income (loss) from discontinued operations before income taxes   52   (832)   6,216   329 (Provision for) benefit from income taxes   (14)   212   (1,578)   (84) Income (loss) from discontinued operations   38   (620)   4,638   245 Net income and comprehensive income  $ 60,832  $ 36,821  $ 182,853  $ 87,358  Earnings (loss) per share:  Basic:  Continuing operations  $ 1.64  $ 0.97  $ 4.76  $ 2.18 Discontinued operations  $ 0.00  $ (0.02)  $ 0.12  $ 0.01 Total basic earnings per share  $ 1.64  $ 0.95  $ 4.88  $ 2.18 Diluted:  Continuing operations  $ 1.59  $ 0.94  $ 4.62  $ 2.13 Discontinued operations  $ 0.00  $ (0.02)  $ 0.12  $ 0.01 Total diluted earnings per share  $ 1.59  $ 0.93  $ 4.74  $ 2.14  Weighted-average shares outstanding:  Basic shares   37,140   38,713   37,434   40,000 Diluted shares   38,233   39,636   38,583   40,874

Adtalem Global Education Inc. Consolidated Statements of Cash Flows (unaudited) (in thousands)  Nine Months Ended March 31, 2025  2024 Operating activities:  Net income  $ 182,853   $ 87,358  Income from discontinued operations   (4,638 )   (245 ) Income from continuing operations   178,215    87,113  Adjustments to reconcile net income to net cash provided by operating activities:  Stock-based compensation   31,181    19,405  Amortization and impairments to operating lease assets   25,330    24,705  Depreciation   30,267    29,879  Amortization of acquired intangible assets   8,415    28,296  Amortization of debt discount and issuance costs   4,995    4,550  Provision for bad debts   46,854    35,741  Deferred income taxes   19,994    (4,650 ) Loss on disposals and impairments of property and equipment   2,522    50  Gain on investments   (268 )   (1,281 ) Unrealized loss on assets held for sale   —    647  Changes in assets and liabilities:  Accounts and financing receivables   (80,613 )   (73,661 ) Prepaid expenses and other current assets   5,727    (2,484 ) Cloud computing implementation assets   (21,959 )   (19,262 ) Accounts payable   (9,978 )   12,632  Accrued payroll and benefits   1,406    15,671  Accrued liabilities   (10,449 )   39,748  Deferred revenue   66,081    60,935  Operating lease liabilities   (17,839 )   (28,448 ) Other assets and liabilities   (6,068 )   (2,475 ) Net cash provided by operating activities-continuing operations   273,813    227,111  Net cash provided by operating activities-discontinued operations   4,394    8,396  Net cash provided by operating activities   278,207    235,507  Investing activities:  Capital expenditures   (31,337 )   (32,316 ) Proceeds from sales of marketable securities   3,120    626  Purchases of marketable securities   (2,048 )   (498 ) Net cash used in investing activities   (30,265 )   (32,188 ) Financing activities:  Proceeds from exercise of stock options   10,008    15,412  Employee taxes paid on withholding shares   (12,457 )   (6,600 ) Proceeds from stock issued under Colleague Stock Purchase Plan   922    581  Repurchases of common stock for treasury   (146,436 )   (250,463 ) Proceeds from issuance of long-term debt   9,873    1,896  Repayments of long-term debt   (109,873 )   (51,896 ) Net cash used in financing activities

...   (247,963 )   (291,070 ) Net decrease in cash, cash equivalents and restricted cash   (21 )   (87,751 ) Cash, cash equivalents and restricted cash at beginning of period   221,202    275,075  Cash, cash equivalents and restricted cash at end of period  $ 221,181   $ 187,324  Non-cash investing and financing activities:  Accrued capital expenditures  $ 12,410   $ 6,217  Accrued liability for repurchases of common stock  $ 4,879   $ 2,995  Accrued excise tax on share repurchases  $ 1,055   $ 3,257

Adtalem Global Education Inc. Segment Information (unaudited) (in thousands)  Three Months Ended  Nine Months Ended March 31,  March 31, Increase/(Decrease)        Increase/(Decrease) 2025   2024   $  %  2025   2024   $  % Revenue:  Chamberlain  $ 192,592   $ 170,338   $ 22,254   13.1 %  $ 541,508   $ 466,487   $ 75,021   16.1 % Walden   178,418    150,607    27,811   18.5 %   511,237    439,023    72,214   16.4 % Medical and Veterinary   95,045    91,713    3,332   3.6 %   278,439    269,235    9,204   3.4 % Total consolidated revenue  $ 466,055   $ 412,658   $ 53,397   12.9 %  $ 1,331,184   $ 1,174,745   $ 156,439   13.3 % Operating income (loss):  Chamberlain  $ 47,516   $ 43,349   $ 4,167   9.6 %  $ 115,716   $ 97,313   $ 18,403   18.9 % Walden   45,194    23,585    21,609   91.6 %   133,929    47,121    86,808   184.2 % Medical and Veterinary   17,800    22,759    (4,959 )  (21.8 )%   53,934    59,142    (5,208 )  (8.8 )% Home Office   (20,001 )   (27,968 )   7,967   28.5 %   (38,962 )   (55,045 )   16,083   29.2 % Total consolidated operating income  $ 90,509   $ 61,725   $ 28,784   46.6 %  $ 264,617   $ 148,531   $ 116,086   78.2 %

Non-GAAP Financial Measures and Reconciliations

We believe that certain non-GAAP financial measures provide investors with useful supplemental information regarding the underlying business trends and performance of Adtalem’s ongoing operations as seen through the eyes of management and are useful for period-over-period comparisons. We use these supplemental non-GAAP financial measures internally in our assessment of performance and budgeting process. However, these non-GAAP financial measures should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. The following are non-GAAP financial measures used in the subsequent GAAP to non-GAAP reconciliation tables:

Adjusted net income (most comparable GAAP measure: net income) – Measure of Adtalem’s net income adjusted for restructuring expense, business integration expense, amortization of acquired intangible assets, write-off of debt discount and issuance costs, litigation reserve, asset impairments, loss on assets held for sale, debt modification costs, strategic advisory costs, and (income) loss from discontinued operations.

Adjusted earnings per share (most comparable GAAP measure: diluted earnings per share) – Measure of Adtalem’s diluted earnings per share adjusted for restructuring expense, business integration expense, amortization of acquired intangible assets, write-off of debt discount and issuance costs, litigation reserve, asset impairments, loss on assets held for sale, debt modification costs, strategic advisory costs, and (income) loss from discontinued operations.

Adjusted operating income (most comparable GAAP measure: operating income) – Measure of Adtalem’s operating income adjusted for restructuring expense, business integration expense, amortization of acquired intangible assets, litigation reserve, asset impairments, strategic advisory costs, loss on assets held for sale, and debt modification costs. This measure is applied on a consolidated and segment basis, depending on the context of the discussion.

Adjusted EBITDA (most comparable GAAP measure: net income) – Measure of Adtalem’s net income adjusted for (income) loss from discontinued operations, interest expense, other income, net, provision for income taxes, depreciation, amortization of acquired intangible assets, amortization of cloud computing implementation assets, stock-based compensation, restructuring expense, business integration expense, litigation reserve, asset impairments, strategic advisory costs, loss on assets held for sale, and debt modification costs. This measure is applied on a consolidated and segment basis, depending on the context of the discussion. Provision for income taxes, interest expense, and other income, net is not recorded at the reportable segments, and therefore, the segment adjusted EBITDA reconciliations begin with operating income.

Free cash flow (most comparable GAAP measure: net cash provided by operating activities-continuing operations) – Defined as net cash provided by operating activities-continuing operations less capital expenditures.

Net debt – Defined as long-term debt less cash and cash equivalents.

Net leverage – Defined as net debt divided by adjusted EBITDA.

A description of special items in our non-GAAP financial measures described above are as follows:

Restructuring expense primarily related to workforce reductions, costs to exit certain course offerings, and prior real estate consolidations at Adtalem’s home office. We do not include normal, recurring, cash operating expenses in our restructuring expense. Business integration expense include expenses related to the Walden acquisition and certain costs related to growth transformation initiatives. We do not include normal, recurring, cash operating expenses in our business integration expense. Amortization of acquired intangible assets. Amortization of cloud computing implementation assets. Write-off of debt discount and issuance costs related to prepayments of debt, reserves related to significant litigation, asset impairments related to adjusting certain operating lease assets and property and equipment as a result of adjusting carrying values to fair values, loss on assets held for sale related to adjusting those assets to estimated fair value less costs to sell, and debt modification costs related to refinancing our Term Loan B loan. Strategic advisory costs related to expanding capabilities and bringing new capacities to market to further enhance our strategic position. We do not include normal, recurring, cash operating expenses in our strategic advisory costs. (Income) loss from discontinued operations includes expense from ongoing litigation costs and settlements related to divestitures and the earn-outs we received.

Adtalem Global Education Inc. Non-GAAP Operating Income by Segment (unaudited) (in thousands)  Three Months Ended  Nine Months Ended March 31,  March 31, Increase/(Decrease)        Increase/(Decrease) 2025   2024   $  %  2025   2024   $  % Chamberlain:  Operating income (GAAP)  $ 47,516   $ 43,349   $ 4,167   9.6 %  $ 115,716   $ 97,313   $ 18,403   18.9 % Restructuring expense   (23 )   —    (23 )     1,912    —    1,912  Adjusted operating income (non-GAAP)  $ 47,493   $ 43,349   $ 4,144   9.6 %  $ 117,628   $ 97,313   $ 20,315   20.9 % Operating margin (GAAP)   24.7 %   25.4 %        21.4 %   20.9 %  Operating margin (non-GAAP)   24.7 %   25.4 %        21.7 %   20.9 %   Walden:  Operating income (GAAP)  $ 45,194   $ 23,585   $ 21,609   91.6 %  $ 133,929   $ 47,121   $ 86,808   184.2 % Restructuring expense   —    —    —      —    (776 )   776  Amortization of acquired intangible assets   2,805    8,286    (5,481 )     8,415    28,296    (19,881 )  Litigation reserve   —    —    —      (5,550 )   18,500    (24,050 )  Adjusted operating income (non-GAAP)  $ 47,999   $ 31,871   $ 16,128   50.6 %  $ 136,794   $ 93,141   $ 43,653   46.9 % Operating margin (GAAP)   25.3 %   15.7 %        26.2 %   10.7 %  Operating margin (non-GAAP)   26.9 %   21.2 %        26.8 %   21.2 %   Medical and Veterinary:  Operating income (GAAP)  $ 17,800   $ 22,759   $ (4,959 )  (21.8 )%  $ 53,934   $ 59,142   $ (5,208 )  (8.8 )% Restructuring expense   121    194    (73 )     236    379    (143 )  Adjusted operating income (non-GAAP)  $ 17,921   $ 22,953   $ (5,032 )  (21.9 )%  $ 54,170   $ 59,521   $ (5,351 )  (9.0 )% Operating margin (GAAP)   18.7 %   24.8 %        19.4 %   22.0 %  Operating margin (non-GAAP)   18.9 %   25.0 %        19.5 %   22.1 %   Home Office:  Operating loss (GAAP)  $ (20,001 )  $ (27,968 )  $ 7,967   28.5 %  $ (38,962 )  $ (55,045 )  $ 16,083   29.2 % Restructuring expense   412    279    133      778    1,614    (836 )  Business integration expense   —    18,450    (18,450 )     —    30,621    (30,621 )  Asset impairments   6,442    —    6,442      6,442    —    6,442  Strategic advisory costs   5,100    —    5,100      5,100    —    5,100  Loss on assets held for sale   —    —    —      —    647    (647 )  Debt modification costs   —    848    (848 )     712    848    (136 )  Adjusted operating loss (non-GAAP)  $ (8,047 )  $ (8,391 )  $ 344   4.1 %  $ (25,930 )  $ (21,315 )  $ (4,615 )  (21.7 )%  Adtalem Global Education:  Operating income (GAAP)  $ 90,509   $ 61,725   $ 28,784   46.6 %  $ 264,617   $ 148,531   $ 116,086   78.2 % Restructuring expense   510    473    37      2,926    1,217    1,709  Business integration expense   —    18,450    (18,450 )     —    30,621    (30,621 )  Amortization of acquired intangible assets   2,805    8,286    (5,481 )     8,415    28,296    (19,881 )  Litigation reserve   —    —    —      (5,550 )   18,500    (24,050 )  Asset impairments   6,442    —    6,442      6,442    —    6,442  Strategic advisory costs   5,100    —    5,100      5,100    —    5,100  Loss on assets held for sale   —    —    —      —    647    (647 )  Debt modification costs   —    848    (848 )     712    848    (136 )  Adjusted operating income (non-GAAP)  $ 105,366   $ 89,782   $ 15,584   17.4 %  $ 282,662   $ 228,660   $ 54,002   23.6 % Operating margin (GAAP)   19.4 %   15.0 %        19.9 %   12.6 %  Operating margin (non-GAAP)   22.6 %   21.8 %        21.2 %   19.5 %

Adtalem Global Education Inc. Non-GAAP Adjusted EBITDA by Segment (unaudited) (in thousands)  Three Months Ended  Nine Months Ended March 31,  March 31, Increase/(Decrease)        Increase/(Decrease) 2025   2024   $  %  2025   2024   $  % Chamberlain:  Operating income (GAAP)  $ 47,516   $ 43,349   $ 4,167   9.6 %  $ 115,716   $ 97,313   $ 18,403   18.9 % Restructuring expense   (23 )   —    (23 )     1,912    —    1,912  Depreciation   5,350    4,938    412      16,184    13,840    2,344  Amortization of cloud computing implementation assets   786    374    412      2,253    950    1,303  Stock-based compensation   3,178    1,795    1,383      10,290    6,791    3,499  Adjusted EBITDA (non-GAAP)  $ 56,807   $ 50,456   $ 6,351   12.6 %  $ 146,355   $ 118,894   $ 27,461   23.1 % Adjusted EBITDA margin (non-GAAP)   29.5 %   29.6 %        27.0 %   25.5 %  Walden:  Operating income (GAAP)  $ 45,194   $ 23,585   $ 21,609   91.6 %  $ 133,929   $ 47,121   $ 86,808   184.2 % Restructuring expense   —    —    —      —    (776 )   776  Amortization of acquired intangible assets   2,805    8,286    (5,481 )     8,415    28,296    (19,881 )  Litigation reserve   —    —    —      (5,550 )   18,500    (24,050 )  Depreciation   1,951    1,835    116      5,428    5,735    (307 )  Amortization of cloud computing implementation assets   763    379    384      2,242    946    1,296  Stock-based compensation   3,288    1,770    1,518      9,354    5,822    3,532  Adjusted EBITDA (non-GAAP)  $ 54,001   $ 35,855   $ 18,146   50.6 %  $ 153,818   $ 105,644   $ 48,174   45.6 % Adjusted EBITDA margin (non-GAAP)   30.3 %   23.8 %        30.1 %   24.1 %  Medical and Veterinary:  Operating income (GAAP)  $ 17,800   $ 22,759   $ (4,959 )  (21.8 )%  $ 53,934   $ 59,142   $ (5,208 )  (8.8 )% Restructuring expense   121    194    (73 )     236    379    (143 )  Depreciation   2,785    3,033    (248 )     8,098    8,897    (799 )  Amortization of cloud computing implementation assets   304    141    163      902    331    571  Stock-based compensation   1,848    851    997      5,613    3,687    1,926  Adjusted EBITDA (non-GAAP)  $ 22,858   $ 26,978   $ (4,120 )  (15.3 )%  $ 68,783   $ 72,436   $ (3,653 )  (5.0 )% Adjusted EBITDA margin (non-GAAP)   24.0 %   29.4 %        24.7 %   26.9 %  Home Office:  Operating loss (GAAP)  $ (20,001 )  $ (27,968 )  $ 7,967   28.5 %  $ (38,962 )  $ (55,045 )  $ 16,083   29.2 % Restructuring expense   412    279    133      778    1,614    (836 )  Business integration expense   —    18,450    (18,450 )     —    30,621    (30,621 )  Asset impairments   6,442    —    6,442      6,442    —    6,442  Strategic advisory costs   5,100    —    5,100      5,100    —    5,100  Loss on assets held for sale   —    —    —      —    647    (647 )  Debt modification costs   —    848    (848 )     712    848    (136 )  Depreciation   188    692    (504 )     557    1,407    (850 )  Stock-based compensation   1,949    1,484    465      5,924    3,105    2,819  Adjusted EBITDA (non-GAAP)  $ (5,910 )  $ (6,215 )  $ 305   4.9 %  $ (19,449 )  $ (16,803 )  $ (2,646 )  (15.7 )% Adtalem Global Education:  Net income (GAAP)  $ 60,832   $ 36,821   $ 24,011   65.2 %  $ 182,853   $ 87,358   $ 95,495   109.3 % (Income) loss from discontinued operations   (38 )   620    (658 )     (4,638 )   (245 )   (4,393 )  Interest expense   13,074    16,560    (3,486 )     41,465    48,910    (7,445 )  Other income, net   (1,898 )   (2,871 )   973      (6,779 )   (8,648 )   1,869  Provision for income taxes   18,539    10,595    7,944      51,716    21,156    30,560  Operating income (GAAP)   90,509    61,725    28,784      264,617    148,531    116,086  Depreciation and amortization   14,932    19,678    (4,746 )     44,079    60,402    (16,323 )  Stock-based compensation   10,263    5,900    4,363      31,181    19,405    11,776  Restructuring expense   510    473    37      2,926    1,217    1,709  Business integration expense   —    18,450    (18,450 )     —    30,621    (30,621 )  Litigation reserve   —    —    —      (5,550 )   18,500    (24,050 )  Asset impairments   6,442    —    6,442      6,442    —    6,442  Strategic advisory costs   5,100    —    5,100      5,100    —    5,100  Loss on assets held for sale   —    —    —      —    647    (647 )  Debt modification costs   —    848    (848 )     712    848    (136 )  Adjusted EBITDA (non-GAAP)  $ 127,756   $ 107,074   $ 20,682   19.3 %  $ 349,507   $ 280,171   $ 69,336   24.7 % Adjusted EBITDA margin (non-GAAP)   27.4 %   25.9 %        26.3 %   23.8 %

Adtalem Global Education Inc. Non-GAAP Earnings Disclosure (unaudited) (in thousands, except per share data)  Three Months Ended  Nine Months Ended March 31,  March 31, 2025   2024   2025   2024  Net income (GAAP)  $ 60,832   $ 36,821   $ 182,853   $ 87,358  Restructuring expense   510    473    2,926    1,217  Business integration expense   —    18,450    —    30,621  Amortization of acquired intangible assets   2,805    8,286    8,415    28,296  Write-off of debt discount and issuance costs, litigation reserve, asset impairments, loss on assets held for sale, and debt modification costs   8,180    1,961    3,342    21,108  Strategic advisory costs   5,100    —    5,100    —  Income tax impact on non-GAAP adjustments (1)   (4,134 )   (7,260 )   (4,821 )   (19,355 ) (Income) loss from discontinued operations   (38 )   620    (4,638 )   (245 ) Adjusted net income (non-GAAP)  $ 73,255   $ 59,351   $ 193,177   $ 149,000

(1) Represents the income tax impact of non-GAAP continuing operations adjustments that is recognized in our GAAP financial statements.

Three Months Ended  Nine Months Ended March 31,  March 31, 2025   2024   2025   2024  Diluted earnings per share (GAAP)  $ 1.59   $ 0.93   $ 4.74   $ 2.14  Effect on diluted earnings per share:  Restructuring expense   0.01    0.01    0.08    0.03  Business integration expense   -    0.47    -    0.75  Amortization of acquired intangible assets   0.07    0.21    0.22    0.69  Write-off of debt discount and issuance costs, litigation reserve, asset impairments, loss on assets held for sale, and debt modification costs   0.21    0.05    0.09    0.52  Strategic advisory costs   0.13    -    0.13    -  Income tax impact on non-GAAP adjustments (1)   (0.11 )   (0.18 )   (0.12 )   (0.47 ) (Income) loss from discontinued operations   (0.00 )   0.02    (0.12 )   (0.01 ) Adjusted earnings per share (non-GAAP)  $ 1.92   $ 1.50   $ 5.01   $ 3.65  Diluted shares used in non-GAAP EPS calculation   38,233    39,636    38,583    40,874

Note: May not sum due to rounding. (1) Represents the income tax impact of non-GAAP continuing operations adjustments that is recognized in our GAAP financial statements.

Adtalem Global Education Inc. Non-GAAP Free Cash Flow Disclosure (unaudited) (in thousands)  Twelve Months Ended FY24  FY24  FY25  FY25  FY25 Q3  Q4  Q1  Q2  Q3 Net cash provided by operating activities-continuing operations (GAAP)  $ 276,843   $ 288,367   $ 291,820   $ 281,971   $ 335,069  Capital expenditures   (44,137 )   (48,893 )   (48,873 )   (50,375 )   (47,914 ) Free cash flow (non-GAAP)  $ 232,706   $ 239,474   $ 242,947   $ 231,596   $ 287,155

Adtalem Global Education Inc. Non-GAAP Net Leverage Disclosure (unaudited) (in thousands)  Twelve Months Ended March 31, 2025 Adtalem Global Education:  Net income (GAAP)  $ 232,272  Income from discontinued operations   (3,457 ) Interest expense   56,214  Other income, net   (8,673 ) Provision for income taxes   56,784  Depreciation and amortization   62,129  Stock-based compensation   37,723  Restructuring expense   3,579  Business integration expense   3,594  Litigation reserve   (5,550 ) Asset impairments   6,442  Strategic advisory costs   5,100  Debt modification costs   712  Adjusted EBITDA (non-GAAP)  $ 446,869   March 31, 2025 Long-term debt  $ 558,283  Less: Cash and cash equivalents   (219,017 ) Net debt (non-GAAP)  $ 339,266   Net leverage (non-GAAP)   0.8 x

View source version on businesswire.com: https://www.businesswire.com/news/home/20250508640032/en/

Contacts

Investor Contact 
Jay Spitzer
[email protected] 
+1 312-906-6600

Media Contact 
Britt Mitchell
[email protected] 
+1 872-270-0301